You have 9 free searches left this month | for more free features.

Luteal phase deficiency

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Osteogenesis Imperfecta Trial in Worldwide (SAR439459, Placebo)

Recruiting
  • Osteogenesis Imperfecta
  • New Haven, Connecticut
  • +9 more
Jan 10, 2023

Advanced Cancer Trial in Durham (pING-hHER3FL)

Recruiting
  • Advanced Cancer
  • pING-hHER3FL
  • Durham, North Carolina
    Duke University Medical Center
Nov 4, 2022

HIV Associated Polyneuropathy Trial in Palm Springs, San Diego (WST-057)

Recruiting
  • HIV Associated Polyneuropathy
  • Palm Springs, California
  • +1 more
Dec 9, 2022

Solid Tumor Trial in Guangzhou (HLX 208)

Recruiting
  • Solid Tumor
  • HLX 208
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
Jan 26, 2022

Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma Trial in Santa Monica (aldoxorubicin, ifosfamide)

Completed
  • Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma
  • Santa Monica, California
    Sarcoma Oncology Center
Jan 27, 2022

Genetic Variants in POI

Recruiting
  • Primary Ovarian Insufficiency
    • Genova, Italy
      UOS Fisiopatologia della Riuproduzione Umana
    Apr 22, 2022

    Covid19 Trial in Tehran (SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline )

    Completed
    • Covid19
    • SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
    • Saline placebo
    • Tehran, Iran, Islamic Republic of
      Espinas Palace Hotel
    Oct 11, 2022

    Covid19 Trial in Tehran (SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant, Saline )

    Completed
    • Covid19
    • SARS-CoV-2 recombinant spike protein + Advax-SM adjuvant
    • Saline placebo
    • Tehran, Iran, Islamic Republic of
      Espinas Palace Hotel
    Oct 11, 2022

    Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Pheochromocytoma, Metastatic Trial in Beijing (anlotinib HCl)

    Recruiting
    • Malignant Adrenal Gland Pheochromocytoma
    • +4 more
    • anlotinib hydrochloride
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Apr 26, 2022

    HIV Trial in Tygerberg Hills (HIVIS DNA/MVA-CMDR, HIVIS DNA + Cervarix and MVA-CMDR, Cervarix)

    Recruiting
    • HIV Infections
    • HIVIS DNA/MVA-CMDR
    • +2 more
    • Tygerberg Hills, Cape Town, South Africa
      Stellenbosch University
    Apr 20, 2022

    Alzheimer Trial in New York, Philadelphia (CT1812, Placebo)

    Completed
    • Alzheimer Disease
    • New York, New York
    • +1 more
    Jan 10, 2022

    Respiratory Syncytial Virus Infections Trial in China (AK0529, Matching of AK0529)

    Completed
    • Respiratory Syncytial Virus Infections
    • AK0529
    • Matching placebo of AK0529
    • Beijing, China
    • +27 more
    Mar 31, 2022

    Colorectal Cancer Screening Trial in Hong Kong (Water method group, Air insufflation group)

    Active, not recruiting
    • Colorectal Cancer Screening
    • Water method group
    • Air insufflation group
    • Hong Kong, Hong Kong
      Centre for Digestive Health, Institute of Digestive Disease, Chi
    Feb 15, 2022

    Glioblastoma Trial (PEP-CMV vaccine)

    Not yet recruiting
    • Glioblastoma
    • PEP-CMV vaccine
    • (no location specified)
    Nov 9, 2023

    Rectal Cancer, Lung Cancer, Ovarian Cancer Trial in Changchun (Bevacizumab injection, Bevacizumab injection(Avastin))

    Completed
    • Rectal Cancer
    • +4 more
    • Bevacizumab injection
    • Bevacizumab injection(Avastin)
    • Changchun, Jilin, China
      Affiliated Hospital of Changchun University of Traditional Chine
    Jul 25, 2022

    IgA Nephropathy Trial in United States (Telitacicept 160mg, Telitacicept 240mg, Placebo)

    Recruiting
    • IgA Nephropathy
    • Telitacicept 160mg
    • +2 more
    • Los Angeles, California
    • +15 more
    Feb 7, 2022

    Critical Illness, Osteoporosis Trial in Australia (Denosumab 60 MG/ML, Zoledronic Acid 5Mg/Bag 100Ml Inj, Sodium Chloride 0.9%

    Recruiting
    • Critical Illness
    • Osteoporosis
    • Denosumab 60 MG/ML
    • +3 more
    • Sydney, New South Wales, Australia
    • +11 more
    Sep 26, 2022

    Atopic Dermatitis Trial in Hamburg, Magdeburg, Wuppertal (si-544, Placebo)

    Recruiting
    • Atopic Dermatitis
    • Hamburg, Germany
    • +3 more
    Sep 27, 2022

    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Invasive Ductal Breast Carcinoma Trial in Boston,

    Active, not recruiting
    • Estrogen Receptor-positive Breast Cancer
    • +5 more
    • PI3K inhibitor BYL719
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Oct 14, 2022

    WHIM Syndrome Trial in Seattle, Fitzroy (X4P-001)

    Active, not recruiting
    • WHIM Syndrome
    • Seattle, Washington
    • +1 more
    Aug 19, 2021

    Amyotrophic Lateral Sclerosis Trial in San Antonio (prosetin, )

    Recruiting
    • Amyotrophic Lateral Sclerosis
    • San Antonio, Texas
      Worldwide Clinical Trials Early Phase Services
    Mar 6, 2022

    Covid19 Trial in Italy (MAD0004J08, Placebo)

    Active, not recruiting
    • Covid19
    • Roma, RM, Italy
    • +13 more
    Feb 2, 2022

    Solid Tumors Trial in Shanghai City (Ipatasertib)

    Active, not recruiting
    • Solid Tumors
    • Shanghai City, China
      Fudan University Shanghai Cancer Center
    Jan 8, 2023

    Mycosis Fungoides, Recurrent Mycosis Fungoides, Recurrent Mycosis Fungoides and Sezary Syndrome Trial in United States

    Recruiting
    • Mycosis Fungoides
    • +11 more
    • Biospecimen Collection
    • +5 more
    • Duarte, California
    • +12 more
    Jan 7, 2023

    Cancer Trial in Santa Monica (Apatinib, Nivolumab)

    Active, not recruiting
    • Cancer
    • Santa Monica, California
      Sarcoma Oncology Research Center
    May 19, 2022